Seer (NASDAQ:SEER) CFO Sells $12,342.07 in Stock

Seer, Inc. (NASDAQ:SEER) CFO David Horn sold 7,303 shares of the business’s stock in a transaction on Wednesday, May 20th. The shares were sold at an average price of $1.69, for a total transaction of $12,342.07. Following the transaction, the chief financial officer owned 493,959 shares in the company, valued at $834,790.71. The trade was a 1.46% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Seer Price Performance

Shares of Seer stock traded up $0.09 during trading on Thursday, reaching $1.77. 215,435 shares of the company traded hands, compared to its average volume of 333,711. Seer, Inc. has a 1-year low of $1.65 and a 1-year high of $2.41. The company has a 50 day moving average price of $1.80 and a 200-day moving average price of $1.88. The firm has a market capitalization of $99.87 million, a PE ratio of -1.43 and a beta of 1.63.

Seer (NASDAQ:SEER) last released its earnings results on Wednesday, May 13th. The company reported ($0.30) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.30). Seer had a negative net margin of 464.78% and a negative return on equity of 26.58%. The company had revenue of $2.79 million for the quarter, compared to the consensus estimate of $3.60 million.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. Occudo Quantitative Strategies LP acquired a new position in Seer during the second quarter worth $25,000. Marshall Wace LLP acquired a new position in Seer during the fourth quarter worth $85,000. Quadrature Capital Ltd acquired a new position in Seer during the fourth quarter worth $101,000. Barclays PLC grew its stake in shares of Seer by 685.0% in the 4th quarter. Barclays PLC now owns 60,717 shares of the company’s stock worth $111,000 after acquiring an additional 52,982 shares in the last quarter. Finally, Corient Private Wealth LLC grew its stake in shares of Seer by 46.3% in the 2nd quarter. Corient Private Wealth LLC now owns 63,200 shares of the company’s stock worth $135,000 after acquiring an additional 20,000 shares in the last quarter. Institutional investors and hedge funds own 75.20% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on SEER shares. Canaccord Genuity Group started coverage on shares of Seer in a report on Monday, May 4th. They set a “buy” rating and a $4.00 price objective on the stock. Weiss Ratings restated a “sell (d-)” rating on shares of Seer in a report on Tuesday, April 21st. Finally, TD Cowen upgraded shares of Seer to a “strong-buy” rating in a report on Monday, April 13th. Two investment analysts have rated the stock with a Strong Buy rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Seer has a consensus rating of “Buy” and an average price target of $4.00.

Seer Company Profile

Seer, Inc is a life sciences company focused on pioneering next-generation proteomics, the large-scale study of proteins and their functions in complex biological systems. By leveraging proprietary nanoparticle-based technology, Seer’s platform enables high-throughput, unbiased protein analysis from biological samples, addressing a critical bottleneck in drug discovery, biomarker research and precision medicine.

The company’s flagship Proteograph Product Suite combines engineered nanoparticle assays with advanced mass spectrometry and bioinformatics pipelines to deliver deep proteomic coverage in a scalable workflow.